New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 9, 2014
09:11 EDTQIHU, SQNM, MCK, BBBY, BIIB, ROVI, DG, YRCW, SGMO, FDO, M, ICPT, JCPOn The Fly: Pre-market Movers
HIGHER: Macy's (M), up 6% after announcing cost reduction initiatives that include cutting 2,500 jobs and issuing FY14 EPS guidance that beat the consensus analyst estimate... Intercept (ICPT), up over 200% after announcing NASH primary endpoint met, FLINT trial stopped early... J.C. Penney (JCP), up 3% after upgraded at Piper Jaffray... McKesson (MCK), up 3.7% after making final offer for Celesio, increases price to EUR 23.50 per share... Sangamo (SGMO), up 14.3% after collaborating with Biogen (BIIB) for hemoglobinopathy treatment development... Sequenom (SQNM), up 10.6% after granted patent by European patent office... DOWN AFTER EARNINGS: Family Dollar (FDO), down 7.3%. Peer Dollar General (DG) down 2.4% in sympathy... Bed Bath & Beyond (BBBY), down 9%... Rovi (ROVI), down 3.4%. ALSO LOWER: Qihoo 360 (QIHU), down 4.5% after China Daily reported the company denied Alibaba's interested in investing... YRC Worldwide (YRCW), down 13% after Teamsters group says union contract extension may be defeated.
News For M;JCP;ICPT;FDO;DG;BBBY;QIHU;ROVI;MCK;SGMO;BIIB;SQNM;YRCW From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
July 16, 2015
05:06 EDTROVIRovi enters into patent license agreement with SK Broadband in Korea
Subscribe for More Information
July 15, 2015
19:08 EDTMStarboard announces stake in Macy's, pushes for real estate spin off, WSJ says
Subscribe for More Information
16:28 EDTMOn The Fly: Top stock stories for Wednesday
Subscribe for More Information
16:00 EDTMOptions Update; July 15, 2015
Subscribe for More Information
12:06 EDTMMacy's calls active, says evaluating real estate ownership structures
Subscribe for More Information
12:00 EDTMMacy's says evaluating real estate ownership structures, Bloomberg reports
Macy's issued the statement to Bloomberg in response to comments made earlier about the value of its real estate assets by Starboard Value CEO Jeff Smith while he spoke at the "Delivering Alpha" conference.
11:37 EDTJCP, MJ.C. Penney rises after Starboard CEO names Macy's 'best idea'
Shares of department store operator Macy's (M) are sharply higher in morning trading after Starboard Value CEO and CIO Jeff Smith revealed his firm has taken a stake in the company and believes its stock could be worth $125 per share. Smith, while speaking at the Delivering Alpha conference, contended that Macy's real estate assets are worth $21B and that it could separate its real estate from its retail business. Shares of Macy's, which Smith called his "best idea" for 2015, is up about 45 to $69.24 after the comments, while J.C. Penney (JCP), which is also a department store operator with real estate assets, is up 1.7% at $9.16. Another peer, Sears (SHLD), is down 2.8% at $23.17, but that is well off its session low of $22.66.
11:28 EDTMStarboard's Smith targeting Macy's, says shares worth $125 each, Bloomberg says
Subscribe for More Information
08:05 EDTROVIRovi reports entertainment discovery patent license agreement with SK Broadband
Subscribe for More Information
07:58 EDTBIIBAnalysts break down impact of $7.2B Receptos buyout
After Celgene (CELG) announced last night that the company has agreed to acquire Receptos (RCPT) for $232 per share in cash, or a total of about $7.2B net of cash acquired, research firms have chimed in with their opinions on how the proposed deal may impact others in the biotech space. Receptos key asset is Ozanimod, which is being studied in Phase III trials for relapsing multiple sclerosis and ulcerative colitis. DERIVATIVE CALLS: Piper Jaffray analyst Edward Tenthoff told investors that he views Celgene's deal for Receptos as good for Arena Pharmaceuticals (ARNA). The analyst notes that Arena's APD334 is already showing dose-dependent decreases in circulating lymphocyte counts and that the company will initiate Phase II studies in ulcerative colitis and Crohn's disease this year. Tenthoff reiterates an Overweight rating and $7.50 price target on Arena, which has a market capitalization around $1B and closed yesterday up 8c to $4.47. In its own note to investors this morning, Nomura said Celgene's deal could put downward pressure on Biogen's (BIIB) long-term multiple sclerosis estimates. Nomura's M. Ian Somaiya contended that one-year Phase II efficacy data for Ozanimod looked as good as Novartis’s (NVS) Gilenya and Biogen's Tecfidera’s Phase III at year 2. Somaiya also wondered if rival Gilead (GILD) could be "looking for something bigger" than Receptos for its own deal, telling investors that the firm views Incyte (INCY) as Gilead's most likely takeout target. Incyte's shares closed up $4.46 at $117.46 yesterday, giving the company a market cap of about $20B. RIVAL BID?: Wedbush analyst Liana Moussatos believes another bidder may seek to acquire Receptos, noting that she previously estimated Receptos could be valued at $348 per share, or about $10.9B, in a buyout. Moussatos noted that Celgene said it expects annual peak sales for Ozanimod to reach about $4B-$6B for RMS and UC, making its acquisition price of $7.2BN only a bit more than about 1X peak sales without accounting for other possible indications or the rest of its pipeline. Moussatos told investors she sees "plenty" of potential upside to justify a rival bidder stepping in and reiterated the firm's Outperform rating on Receptos shares. PRICE ACTION: In pre-market trading, Receptos rose 10% to $228.61 while Gilead gained 1.4% to about $119 per share.
July 14, 2015
11:33 EDTJCPStocks with call strike movement; CHK JCP
Chesapeake (CHK) January 14 call option implied volatility decreased 3% to 55, J.C. Penney (JCP) November 10 call option implied volatility increased 6% to 44 according to IVolatility.
11:05 EDTBIIBForward Pharma, Biogen tell PTO no settlement reached, Markman Advisors says
Subscribe for More Information
10:26 EDTQIHUOptions with decreasing implied volatility
Subscribe for More Information
10:06 EDTBBBYHigh option volume stocks
Subscribe for More Information
10:01 EDTBBBYOn The Fly: Analyst Initiation Summary
8point3 Energy (CAFD) initiated with a Buy at Deutsche Bank... Abraxas Petroleum (AXAS) initiated with a Market Perform at Cowen... Amarantus Bioscience (AMBS) initiated with a Buy at WallachBeth... Ashford Hospitality Prime (AHP) initiated with a Hold at Canaccord... Ashford (AINC) initiated with a Hold at Canaccord... BE Aerospace (BEAV) initiated with a Neutral at JPMorgan... Bed Bath & Beyond (BBBY) initiated with a Neutral at Longbow... Benchmark Electronics (BHE) initiated with a Buy at B. Riley... Bill Barrett (BBG) initiated with a Market Perform at Cowen... Boeing (BA) initiated with an Overweight at JPMorgan... Bombardier (BDRBF) initiated with a Neutral at JPMorgan... Cablevision (CVC) initiated with a Hold at Deutsche Bank... Charter (CHTR) initiated with a Buy at Deutsche Bank... Chesapeake (CHK) initiated with an Equal Weight at Stephens... Comcast (CMCSA) initiated with a Hold at Deutsche Bank... DiamondRock (DRH) initiated with a Buy at Canaccord... Diamondback Energy (FANG) initiated with an Outperform at Cowen... EOG Resources (EOG) initiated with an Overweight at Stephens... Fogo De Chao (FOGO) initiated with a Buy at Jefferies... General Dynamics (GD) initiated with an Overweight at JPMorgan... HP (HPQ) initiated with a Hold at Maxim... Hanover Insurance (THG) initiated with an Overweight at Piper Jaffray... Harris (HRS) initiated with a Neutral at JPMorgan... Hospitality Properties (HPT) initiated with a Hold at Canaccord... Host Hotels (HST) initiated with a Hold at Canaccord... Hydrogenics (HYGS) initiated with a Buy at Rodman & Renshaw... King Digital (KING) initiated with an Overweight at Morgan Stanley... L-3 Communications (LLL) initiated with a Neutral at JPMorgan... La-Z-Boy (LZB) initiated with a Neutral at Longbow... LaSalle Hotel (LHO) initiated with a Hold at Canaccord... MINDBODY (MB) initiated with a Buy at UBS... Marriott (MAR) initiated with a Hold at Canaccord... Newfield Exploration (NFX) initiated with a Buy at Global Hunter... Northern Oil and Gas (NOG) initiated with a Market Perform at Cowen... Northrop Grumman (NOC) initiated with an Underweight at JPMorgan... Oasis Petroleum (OAS) initiated with an Outperform at Cowen... PDC Energy (PDCE) initiated with an Outperform at Cowen... Pier 1 Imports (PIR) initiated with a Buy at Longbow... Plexus (PLXS) initiated with a Buy at B. Riley... Raytheon (RTN) initiated with a Neutral at JPMorgan... RetailMeNot (SALE) initiated with an Equal Weight at Morgan Stanley... Rockwell Collins (COL) initiated with a Neutral at JPMorgan... Spirit AeroSystems (SPR) initiated with an Overweight at JPMorgan... Starwood (HOT) initiated with a Buy at Canaccord... Strategic Hotels (BEE) initiated with a Buy at Canaccord... Summit Hotel Properties (INN) initiated with a Buy at Canaccord... Textron (TXT) initiated with a Neutral at JPMorgan... Time Warner Cable (TWC) initiated with a Buy at Deutsche Bank... TransDigm (TDG) initiated with an Overweight at JPMorgan... TrueCar (TRUE) initiated with an Equal Weight at Morgan Stanley... Whiting Petroleum (WLL) initiated with an Outperform at Cowen... XL Group (XL) initiated with an Overweight at Piper Jaffray... Zillow Group (Z) initiated with an Overweight at Morgan Stanley... Zynga (ZNGA) initiated with an Equal Weight at Morgan Stanley.
10:01 EDTBIIBOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:56 EDTMCKMorgan Stanley names 'Vintage Values 2016' list
Morgan Stanley named its "Vintage Values 2016" list, comprised of the firm's analysts' best ideas to hold over the next 12 months. Included on the list are Ameriprise (AMP), Apple (AAPL), Bank of America (BAC), Comcast (CMCSA), Crown Castle (CC), Estee Lauder (EL), Hilton (HLT), Ingersoll-Rand (IR), LinkedIn (LNKD), Magna (MGA), Marathon Oil (MRO), McKesson (MCK), Oaktree Capital (OAK), Thermo Fisher (TMO) and Visa (V).
08:01 EDTROVIRovi renews patent license pact with VIZIO
Subscribe for More Information
07:28 EDTBIIBBiogen upgraded to Buy from Neutral at BofA/Merrill
Subscribe for More Information
06:59 EDTBBBYBed Bath & Beyond initiated with a Neutral at Longbow
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use